STUDY PERIOD
Start date: July 7, 2021
End date: April 2023
STUDY INFORMATION
Indication: This study is developed to evaluate efficacy and safety in Patients with Mild-to-Moderate Hypertension
Frequency of Visit:
Screening Visit: 2
In Person Visit: 13
STUDY CRITERIA
Age: 18 to 75 years old
Gender: Both
